Guizhou Salvage Pharmaceutical Co.,Ltd. / Fundamentals
Income statement
- Net revenue
€290.62M - Cost of goods sold
€262.61M - Gross profit
€28.01M - SG&A expenses
€12.60M - R&D expenses
€8.45M - EBITDA
-€5.61M - D&A
€0.00 - EBIT
-€10.89M - Interest expenses
€6.26M - EBT
-€11.86M - Tax expenses
-€97.05K - Net income
-€11.77M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€33.87M - Changes in working capital
€0.00 - Operating cash flow
€34.12M - Capex
€12.12M - Other investing cash flow
€68.83K - Net investing cash flow
-€12.05M - Total cash dividends paid
-€5.28M - Issuance of common stock
€0.00 - Debt repayment
-€17.88M - Other financing cash flow
-€14.22M - Net financing cash flow
-€37.38M - Foreign exchange effects
€0.00 - Net change in cash
€4.12M - Cash at end of period
€10.99M - Free cash flow
€46.24M
Balance sheet
- Cash and cash equivalents
€37.62M - Cash and short-term investments
€37.62M - Total receivables
€4.39M - Inventory
€36.51M - Other current assets
€16.94M - Total current assets
€95.45M - Property, plant & equipment
€383.46M - Goodwill
€0.00 - Intangible assets
€43.29M - Long-term investments
€0.00 - Other non-current assets
€25.74M - Total non-current assets
€454.97M - Total assets
€550.43M - Accounts payable
€65.40M - Short-term debt
€67.70M - Other current liabilities
€50.28M - Total current liabilities
€184.12M - Long-term debt
€55.64M - Deferred tax liabilities
€2.50M - Other non-current liabilities
€7.48M - Total non-current liabilities
€68.70M - Total liabilities
€252.83M - Common stock
€200.93M - Retained earnings
-€242.60M - Other equity
€0.00 - Total equity
€297.60M - Total liabilities and shareholders' equity
€550.43M
Company information
- Market capitalization
€500.04M - Employees
1.9K - Enterprise Value
€4.65B
Company ratios
- Gross margin
-
9.6% Worse than peer group: 22.4% - EBITDA margin
-
-1.9% Much worse than peer group: 19.7% - EBIT margin
-
-3.7% Worse than peer group: 11.8% - EBT margin
-
-4.1% Worse than peer group: 12.8% - Net margin
-
-4.0% Worse than peer group: 9.0% - ROE
-
-4.0% Worse than peer group: 6.0% - ROA
-
-2.1% Worse than peer group: 3.9% - Asset turnover
-
52.8% Worse than peer group: 62.1% - FCF margin
-
7.6% Better than peer group: -4.3% - FCF yield
4.4% - Efficiency ratio
101.9% - Net sales per employee
-
€153.77K - Net income per employee
-
-€6.23K